Edgewise Therapeutics Inc (EWTX) — Working Capital to Net Assets Ratio
Edgewise Therapeutics Inc (EWTX) has a Working Capital to Net Assets ratio of 98.8% as of March 2026. Working capital of $487.25 Million (current assets of $509.79 Million minus current liabilities of $22.54 Million) is measured against net assets of $493.20 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Edgewise Therapeutics Inc (EWTX) net asset quality to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Edgewise Therapeutics Inc Working Capital to Net Assets (2019–2025)
This chart shows how Edgewise Therapeutics Inc's Working Capital to Net Assets ratio has evolved across 7 annual periods from 2019 to 2025. As of March 2026, the ratio stands at 98.8%, reflecting working capital of $487.25 Million against net assets of $493.20 Million USD. Check EWTX tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Edgewise Therapeutics Inc (2019–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Edgewise Therapeutics Inc from 2019 to 2025, covering 7 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Edgewise Therapeutics Inc market cap and net worth.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 98.8% | $516.01 Million | $522.26 Million | $543.38 Million | $27.37 Million | ▲ +0.5 pp |
| 2024 | 98.3% | $451.62 Million | $459.22 Million | $475.48 Million | $23.86 Million | ▲ +1.0 pp |
| 2023 | 97.3% | $310.23 Million | $318.83 Million | $327.00 Million | $16.77 Million | ▼ -0.9 pp |
| 2022 | 98.2% | $340.41 Million | $346.72 Million | $357.00 Million | $16.59 Million | ▼ -1.4 pp |
| 2021 | 99.6% | $273.25 Million | $274.38 Million | $283.77 Million | $10.52 Million | ▲ +474.5 pp |
| 2020 | -374.9% | $125.30 Million | $-33.42 Million | $129.65 Million | $4.34 Million | ▼ -239.0 pp |
| 2019 | -135.9% | $22.91 Million | $-16.85 Million | $24.04 Million | $1.13 Million | — |